CJC-1295 w/o DAC 10mg Peptides
When precision matters, start with a compound engineered for consistency.
The Well Elevation CJC-1295 without DAC lyophilized research peptide is presented as a clean, stable powder in a sealed vial, designed for controlled laboratory workflows. This growth hormone–releasing hormone analog is prepared for researchers who require dependable material handling and clear documentation. Each unit provides a total content of 10mg in a lyophilized vial format, offering a straightforward foundation for methodical study design.
- Each vial contains 10mg of CJC-1295 w/o DAC, a GHRH analog frequently evaluated for protocol flexibility, short-interval study designs, and consistent performance under standardized laboratory conditions.
Developed for non-edible, non-consumer applications, this lyophilized peptide is selected for its stability profile and predictable handling characteristics. Researchers can expect a crisp, low-residue powder that supports accurate measurement, controlled reconstitution under proper laboratory technique, and reliable aliquoting. The vial format is intended to streamline bench setup, minimize variables, and maintain sample integrity from receipt to the final data point.
Quality at Well Elevation is systematic and verifiable. This peptide is produced in the United States under cGMP-aligned procedures with rigorous in-process controls. Each lot is qualified by HPLC and mass spectrometry for identity and purity, with detailed documentation and traceability maintained from synthesis through final packaging. Tamper-evident presentation and temperature-aware handling protocols reinforce stability throughout the distribution chain.
Every detail—from raw material selection to final inspection—is managed to support reproducible outcomes. Clear labeling, lot-specific documentation, and careful environmental controls reflect our commitment to laboratory standards. If your work depends on tight tolerances and dependable performance, this CJC-1295 without DAC vial is built to meet those expectations.
Research Use Only: This material is furnished strictly for laboratory research. Not for human consumption, medical, veterinary, or household use. By purchasing, you acknowledge and agree to handle and store according to applicable regulations and your institution’s safety protocols.
Well Elevation prioritizes purity, consistency, and transparency—delivering research peptides that align with serious scientific practice.
- Most orders ship within 24 hours and arrive within 3 to 5 days of leaving our warehouse.
- Shipping is free on orders of $99+ (except Hawaii and Alaska).
- All orders ship in discreet packaging via USPS Ground Advantage mail.
Delivery restrictions vary by state.
This Product Contains
Customer Reviews
There are no reviews yet. Be the first to write a review!
Frequently Asked Questions
What are GH peptides?
GH peptides — short for growth-hormone-related peptides — are a research category that includes two main subgroups. The first is growth-hormone-releasing hormone (GHRH) analogs, such as Sermorelin, Tesamorelin, and CJC-1295, which are studied for their interaction with the GHRH receptor. The second is growth hormone secretagogues, such as Ipamorelin, GHRP-2, GHRP-6, and Hexarelin, which are studied for their interaction with the ghrelin receptor (GHS-R1a).
Both subgroups are investigated in the research context of growth-hormone-axis biology. All GH peptide products from Well Elevation are lyophilized research compounds intended solely for in vitro laboratory investigation.
How do GH peptides differ from recombinant growth hormone?
Recombinant human growth hormone is the full 191-amino-acid human GH protein, produced via recombinant DNA technology. It is essentially identical to the endogenous hormone itself. GH peptides, by contrast, are much shorter sequences — typically on the order of a few to a few dozen amino acids — that do not act as GH themselves but rather engage upstream receptors (GHRH-R or GHS-R1a) involved in the GH signaling axis.
This makes the two categories mechanistically distinct. Recombinant GH is a replacement of the hormone itself, while GH peptides are research tools for studying the regulatory machinery that controls endogenous GH release.
What is the difference between GHRH analogs and GH secretagogues?
GHRH analogs are peptides modeled on the natural growth-hormone-releasing hormone sequence. They are studied for their ability to bind the GHRH receptor on the pituitary — the same receptor used by endogenous GHRH. Examples include Sermorelin (a GHRH 1-29 analog), Tesamorelin, and CJC-1295.
GH secretagogues are a structurally different class of peptides that act through the growth hormone secretagogue receptor (GHS-R1a), better known as the ghrelin receptor. Examples include Ipamorelin, GHRP-2, GHRP-6, and Hexarelin. The two classes engage different receptors and are therefore studied as distinct pharmacological families in research on GH signaling.
